> Detailanzeige

Kremer, Thomas [Verfasser:in]; Taylor, Kirsten I. [Verfasser:in]; Coffey, Christopher S. [Verfasser:in]; Simuni, Tanya [Verfasser:in]; Weintraub, Daniel [Verfasser:in]; Seibyl, John [Verfasser:in]; Poston, Kathleen L. [Verfasser:in]; Toga, Arthur W. [Verfasser:in]; Tanner, Caroline M. [Verfasser:in]; Marek, Kenneth [Verfasser:in]; Hutten, Samantha J. [Verfasser:in]; Dziadek, Sebastian [Verfasser:in]; Siebourg-Polster, Juliane [Verfasser:in]; Trenkwalder, Claudia [Verfasser:in]; Pagano, Gennaro [Verfasser:in]; Mollenhauer, Brit [Verfasser:in]; Gerken, Thomas [Verfasser:in]; Staempfli, Andreas [Verfasser:in]; Czech, Christian [Verfasser:in]; Dukart, Juergen [Verfasser:in]; Galasko, Douglas [Verfasser:in]; Foroud, Tatiana [Verfasser:in]; Chahine, Lana M. [Verfasser:in]

Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
  • Beteiligte: Kremer, Thomas [Verfasser:in]; Taylor, Kirsten I. [Verfasser:in]; Coffey, Christopher S. [Verfasser:in]; Simuni, Tanya [Verfasser:in]; Weintraub, Daniel [Verfasser:in]; Seibyl, John [Verfasser:in]; Poston, Kathleen L. [Verfasser:in]; Toga, Arthur W. [Verfasser:in]; Tanner, Caroline M. [Verfasser:in]; Marek, Kenneth [Verfasser:in]; Hutten, Samantha J. [Verfasser:in]; Dziadek, Sebastian [Verfasser:in]; Siebourg-Polster, Juliane [Verfasser:in]; Trenkwalder, Claudia [Verfasser:in]; Pagano, Gennaro [Verfasser:in]; Mollenhauer, Brit [Verfasser:in]; Gerken, Thomas [Verfasser:in]; Staempfli, Andreas [Verfasser:in]; Czech, Christian [Verfasser:in]; Dukart, Juergen [Verfasser:in]; Galasko, Douglas [Verfasser:in]; Foroud, Tatiana [Verfasser:in]; Chahine, Lana M. [Verfasser:in]
  • Erschienen: Wiley, 2021
  • Erschienen in: Movement disorders 36(8), 1972-1978 (2021). doi:10.1002/mds.28608
  • Sprache: Englisch
  • DOI: https://doi.org/10.1002/mds.28608
  • ISSN: 0885-3185; 1531-8257
  • Entstehung:
  • Anmerkungen: Diese Datenquelle enthält auch Bestandsnachweise, die nicht zu einem Volltext führen.
  • Beschreibung: Background: Cerebrospinal fluid (CSF) levels of monoamine metabolites may represent biomarkers of Parkinson's disease (PD).Objective: The aim of this study was quantification of multiple metabolites in CSF from PD versus healthy control subjects (HCs), including longitudinal analysis.Methods: Absolute levels of multiple monoamine metabolites in CSF were quantified by liquid chromatography coupled with tandem mass spectrometry from 161 individuals with early PD and 115 HCs from the Parkinson's Progression Marker Initiative and de novo PD (DeNoPA) studies.Results: Baseline levels of homovanillic acid (HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC) were lower in individuals with PD compared with HCs. HVA levels correlated with Movement Disorder Society Unified Parkinson's Disease Rating Scale total scores (P < 0.01). Both HVA/dopamine and DOPAC/dopamine levels correlated with caudate nucleus and raw DOPAC with putamen dopamine transporter single-photon emission computed tomography uptake ratios (P < 0.01). No metabolite changed over 2 years in drug-naive individuals, but some changed on starting levodopa treatment.Conclusions: HVA and DOPAC CSF levels mirrored nigrostriatal pathway damage, confirming the central role of dopaminergic degeneration in early PD. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.Keywords: CSF; Parkinson's disease; biomarker; catecholamine; homovanillic acid; monoamine metabolites; neurotransmitter.
  • Zugangsstatus: Freier Zugang